Plasticity of disseminating cancer cells in patients with epithelial malignancies

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 673-687

  Bednarz Knoll, Natalia ^a   Alix Panabières, Catherine ^b,c,d   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HÔPITAL SAINT ELOI   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

Cancer progression; Cell plasticity; CTC; Dissemination; EMT; MET; Metastasis

Indexed keywords

FIBRONECTIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; VIMENTIN;

ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CANCER PATIENT; CELL PLASTICITY; CELL TRANSFORMATION; CIRCULATING TUMOR CELL; DYNAMICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM TUMOR; HUMAN; LUNG CANCER; MESENCHYMAL EPITHELIAL TRANSITION; METASTASIS; MICROMETASTASIS; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; BIOLOGICAL MARKERS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM MICROMETASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC CELLS, CIRCULATING;

EID: 84867985453     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9370-z     Document Type: Article

References (146)

1. Pantel, K.; & Brakenhoff, R. H. (2004). Dissecting the metastatic cascade. Nature Reviews Cancer, 4(6), 448-456.
2. Pantel, K.; Brakenhoff, R. H.; & Brandt, B. (2008). Detection, clinical relevance and specific biological properties of disseminating tumor cells. Nature Reviews Cancer, 8(5), 329-340.
3. Pantel, K.; Alix-Panabières, C.; & Riethdorf, S. (2009). Cancer micrometastases. Nature Reviews Clinical Oncology, 6(6), 339-351.
4. Bednarz-Knoll, N.; Alix-Panabières, C.; & Pantel, K. (2011). Clinical relevance and biology of circulating tumor cells. Breast Cancer Research, 3(6), 228.
5. Alix-Panabières, C.; Schwarzenbach, H.; & Pantel, K. (2012). Circulating tumor cells and circulating tumor DNA. Annual Review of Medicine, 63, 199-215.
6. Budd, G. T.; Cristofanilli, M.; Ellis, M. J.; Stopeck, A.; Borden, E.; Miller, M. C.; Matera, J.; Repollet, M.; Doyle, G. V.; Terstappen, L. W.; & Hayes, D. F. (2006). Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clinical Cancer Research, 12(21), 6403-6409.
7. Cohen, S. J.; Punt, C. J.; Iannotti, N.; Saidman, B. H.; Sabbath, K. D.; Gabrail, N. Y.; Picus, J.; Morse, M.; Mitchell, E.; Miller, M. C.; Doyle, G. V.; Tissing, H.; Terstappen, L. W.; & Meropol, N. J. (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 26(19), 3213-3221.
8. de Bono, J. S.; Scher, H. I.; Montgomery, R. B.; Parker, C.; Miller, M. C.; Tissing, H.; Doyle, G. V.; Terstappen, L. W.; Pienta, K. J.; & Raghavan, D. (2008). Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical Cancer Research, 14(19), 6302-6309.
9. Thompson, E. W.; & Williams, E. D. (2008). EMT and MET in carcinoma-clinical observations, regulatory pathways and new models. Clinical and Experimental Metastasis, 25(6), 591-592.
10. Polyak, K.; & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews Cancer, 9(4), 265-273.
11. Thiery, J. P.; Acloque, H.; Huang, R. Y.; & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871-890.
12. Thiery, J. P.; & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7(2), 131-142.
13. Zeisberg, M.; & Neilson, E. G. (2009). Biomarkers for epithelial-mesenchymal transitions. Journal of Clinical Investigation, 119(6), 1429-1437.
14. Sleeman, J. P.; & Thiery, J. P. (2011). SnapShot: the epithelial-mesenchymal transition. Cell, 145(1), 162.e1.
15. Kalluri, R.; & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119(6), 1420-1428.
16. Bonnomet, A.; Brysse, A.; Tachsidis, A.; Waltham, M.; Thompson, E. W.; Polette, M.; & Gilles, C. (2010). Epithelial-to-mesenchymal transitions and circulating tumor cells. Journal of Mammary Gland Biology and Neoplasia, 15(2), 261-273.
17. Thompson, E. W.; & Haviv, I. (2011). The social aspects of EMT-MET plasticity. Nature Medicine, 17(9), 1101-1109.
18. Chambers, A. F.; Groom, A. C.; & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2(8), 563-572.
19. Hanahan, D.; & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
20. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews Cancer, 9(4), 302-312.
21. Rhim, A. D.; Mirek, E. T.; Aiello, N. M.; Maitra, A.; Bailey, J. M.; McAllister, F.; Reichert, M.; Beatty, G. L.; Rustgi, A. K.; Vonderheide, R. H.; Leach, S. D.; & Stanger, B. Z. (2012). EMT and dissemination precede pancreatic tumor formation. Cell, 148(1-2), 349-361.
22. Hüsemann, Y.; Geigl, J. B.; Schubert, F.; Musiani, P.; Meyer, M.; Burghart, E.; Forni, G.; Eils, R.; Fehm, T.; Riethmüller, G.; & Klein, C. A. (2008). Systemic spread is an early step in breast cancer. Cancer Cell, 13(1), 58-68.
23. Sänger, N.; Effenberger, K. E.; Riethdorf, S.; Van Haasteren, V.; Gauwerky, J.; Wiegratz, I.; Strebhardt, K.; Kaufmann, M.; & Pantel, K. (2011). Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. International Journal of Cancer, 129(10), 2522-2526.
24. Pantel, K.; Denève, E.; Nocca, D.; Coffy, A.; Vendrell, J. P.; Maudelonde, T.; Riethdorf, S.; & Alix-Panabières, C. (2012). Circulating epithelial cells in patients with benign colon diseases. Clinical Chemistry, 58, 936-940.
25. Joyce, J. A.; & Pollard, J. W. (2009). Microenvironmental regulation of metastasis. Nature Reviews Cancer, 9(4), 239-252.
26. Schmidt, H.; De Angelis, G.; Eltze, E.; Gockel, I.; Semjonow, A.; & Brandt, B. (2006). Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harbouring loss of heterozygosity of the PTEN gene. Cancer Research, 66(18), 8959-8965.
27. Swennenhuis, J. F.; Tibbe, A. G. J.; Levink, R.; Sipkema, R. C. J.; & Terstappen, L. W. (2009). Characterization of circulating tumour cells by fluorescence in situ hybridization. Cytometry A, 75(6), 520-527.
28. Hou, J. M.; Krebs, M.; Ward, T.; Sloane, R.; Priest, L.; Hughes, A.; Clack, G.; Ranson, M.; Blackhall, F.; & Dive, C. (2011). Circulating tumor cells as a window on metastasis biology in lung cancer. The American Journal of Pathology, 178(3), 989-996.
29. Khoja, L.; Backen, A.; Sloane, R.; Menasce, L.; Ryder, D.; Krebs, M.; Board, R.; et al. (2011). A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. British Journal of Cancer, 106(3), 508-516.
30. Schmidt, H.; De Angelis, G.; Bettendorf, O.; Eltze, E.; Semjonow, A.; Knichwitz, G.; & Brandt, B. (2004). Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients. International Journal of Biological Markers, 19(2), 93-99.
31. Crane, K. (2011). Elucidating an uncommon disease: inflammatory breast cancer. Journal of National Cancer Institute, 103(18), 1358-1360.
32. Krebs, M. G.; Hou, J.-M.; Sloane, R.; Lancashire, L.; Priest, L.; Nonaka, D.; Ward, T. H.; et al. (2011). Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. Journal of Thoracic Oncology, 7(2), 306-315.
33. Lianidou, E.S.; Markou, A.; Strati, A. (2012). Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment. Cancer & Metastasis Reviews (in press)
34. Kallergi, G.; Agelaki, S.; Kalykaki, A.; Stournaras, C.; Mavroudis, D.; & Georgoulias, V. (2008). Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Research, 10(5), R80.
35. Riethdorf, S.; Müller, V.; Zhang, L.; Rau, T.; Loibl, S.; Komor, M.; Roller, M.; Huober, J.; Fehm, T.; Schrader, I.; Hilfrich, J.; Holms, F.; Tesch, H.; Eidtmann, H.; Untch, M.; von Minckwitz, G.; & Pantel, K. (2010). Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clinical Cancer Research, 16(9), 2634-2645.
36. Aktas, B.; Müller, V.; Tewes, M.; Zeitz, J.; Kasimir-Bauer, S.; Loehberg, C. R.; Rack, B.; Schneeweiss, A.; & Fehm, T. (2011). Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients. Gynecol Oncol, 122(2), 356-360.
37. Banys, M.; Krawczyk, N.; Becker, S.; Jakubowska, J.; Staebler, A.; Wallwiener, D.; Fehm, T.; & Rothmund, R. (2012). The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer. Breast Cancer Research & Treatment, 131(2), 501-508.
38. Gradilone, A.; Naso, G.; Raimondi, C.; Cortesi, E.; Gandini, O.; Vincenti, B.; Saltarelli, R.; Chiapparono, E.; Spremberg, F.; Cristofanilli, M.; Frati, L.; Agliano, A. M.; & Gazzaniga, P. (2011). Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annals of Oncology, 22(1), 86-92.
39. Larson, C. J.; Moreno, J. G.; Pienta, K. J.; Gross, S.; Repollet, M.; O'Hara, S. M.; Russell, T.; & Terstappen, L. W. M. M. (2004). Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A, 62A, 46-53.
40. Rossi, E.; Basso, U.; Celadin, R.; Zilio, F.; Pucciarelli, S.; Aieta, M.; Barile, C.; Sava, T.; Bonciarelli, G.; Tumolo, S.; Ghiotto, C.; Magro, C.; Jirillo, A.; Indraccolo, S.; Amadori, A.; & Zamarchi, R. (2010). M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by cell search analysis. Clinical Cancer Research, 16(21), 5233-5243.
41. Müller, V.; Stahmann, N.; Riethdorf, S.; Rau, T.; Zabel, T.; Goetz, A.; Jänicke, F.; & Pantel, K. (2005). Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clinical Cancer Research, 11(10), 678-3685.
42. Stott, S. L.; Lee, R. J.; Nagrath, S.; Yu, M.; Miyamoto, D. T.; Ulkus, L.; et al. (2010). Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Science Translational Medicine, 2(25), 25ra23.
43. Wyckoff, J. B.; Jones, J. G.; Condeelis, J. S.; & Segall, J. E. (2000). A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Research, 60(9), 2504-2511.
44. Goss, P. E.; & Chambers, A. F. (2010). Does tumour dormancy offer a therapeutic target? Nature Reviews Cancer, 10(12), 871-877.
45. Uhr, J. W.; & Pantel, K. (2011). Controversies in clinical cancer dormancy. Proceedings of the National Academy of Sciences, 108(30), 12396-12400.
46. Psaila, B.; & Lyden, D. (2009). The metastatic niche: adapting the foreign soil. Nature Reviews Cancer, 9(4), 285-293.
47. Sleeman, J. P. (2012). The metastatic niche and stromal progression. Cancer & Metastasis Reviews. doi: 10.1007/s10555-012-9373-9.
48. Nguyen, D. X.; Bos, P. D.; & Massagué, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nature Reviews Cancer, 9(4), 274-284.
49. Navin, N. E.; & Hicks, J. (2010). Tracing the tumor lineage. Molecular Oncology, 4(3), 267-283.
50. Kim, M. Y.; Oskarsson, T.; Acharyya, S.; Nguyen, D. X.; Zhang, X. H.; Norton, L.; & Massagué, J. (2009). Tumor self-seeding by circulating cancer cells. Cell, 139(7), 1315-1326.
51. Comen, E.; Norton, L.; & Massagué, J. (2011). Clinical implications of cancer self-seeding. Nature Reviews Clinical Oncology, 8(6), 369-377.
52. Bidard, F. C.; Vincent-Salomon, A.; Gomme, S.; Nos, C.; de Rycke, Y.; Thiery, J. P.; Sigal-Zafrani, B.; Mignot, L.; Sastre-Garau, X.; Pierga, J. Y.; & Institut Curie Breast Cancer Study Group. (2008). Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Clinical Cancer Research, 14(11), 3306-3311.
53. Bidard, F. C.; Kirova, Y. M.; Vincent-Salomon, A.; Alran, S.; de Rycke, Y.; Sigal-Zafrani, B.; Sastre-Garau, X.; Mignot, L.; Fourquet, A.; & Pierga, J. Y. (2009). Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. Annals of Oncologyl, 20(11), 1836-1841.
54. Cristofanilli, M.; Hayes, D. F.; Budd, G. T.; Ellis, M. J.; Stopeck, A.; Reuben, J. M.; Doyle, G. V.; Matera, J.; Allard, W. J.; Miller, M. C.; Fritsche, H. A.; Hortobagyi, G. N.; & Terstappen, L. W. (2005). Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Journal of Clinical Oncology, 23(7), 1420-1430.
55. Stoecklein, N. H.; & Klein, C. A. (2010). Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. International Journal of Cancer, 126(3), 589-598.
56. Hannemann, J.; Meyer-Staeckling, S.; Kemming, D.; Alpers, I.; Joosse, S. A.; Pospisil, H.; Kurtz, S.; Görndt, J.; Püschel, K.; Riethdorf, S.; Pantel, K.; & Brandt, B. (2011). Quantitative high-resolution genomic analysis of single cancer cells. Public Library of Science One, 6(11), e26362.
57. Vona, G.; Sabile, A.; Louha, M.; Sitruk, V.; Romana, S.; Schütze, K.; Capron, F.; Franco, D.; Pazzagli, M.; Vekemans, M.; Lacour, B.; Bréchot, C.; & Paterlini-Bréchot, P. (2000). Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Americal Journal of Pathology, 156, 57-63.
58. Pinzani, P.; Salvadori, B.; Simi, L.; Bianchi, S.; Distante, V.; Cataliotti, L.; Pazzagli, M.; & Orlando, C. (2006). Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Human Pathology, 37, 711-718.
59. Zheng, S.; Lin, H. K.; Lu, B.; Williams, A.; Datar, R.; Cote, R. J.; & Tai, Y. C. (2011). 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices, 13(1), 203-213.
60. Tan, S. J.; Lakshmi, R. L.; Chen, P.; Lim, W. T.; Yobas, L.; & Lim, C. T. (2010). Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron, 26, 1701-1705.
61. Moon, H. S.; Kwon, K.; Kim, S. I.; Han, H.; Sohn, J.; Lee, S.; & Jung, H. I. (2011). Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip, 11(6), 1118-1125.
62. Gascoyne, P. R.; Noshari, J.; Anderson, T. J.; & Becker, F. F. (2009). Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis, 30, 1388-1398.
63. Bednarz, N.; Eltze, E.; Semjonow, A.; Rink, M.; Andreas, A.; Mulder, L.; Hannemann, J.; Fisch, M.; Pantel, K.; Weier, U.-H. G.; Bielawski, K. P.; & Brandt, B. (2010). BRCA1 loss pre-existing in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood. Clinical Cancer Research, 16(13), 3340-3348.
64. Fehm, T.; Müller, V.; Alix-Panabières, C.; & Pantel, K. (2008). Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Research, 10(Suppl 1), S1.
65. Königsberg, R.; Obermayr, E.; Bises, G.; Pfeiler, G.; Gneist, M.; Wrba, F.; De Santis, M.; Zeillinger, R.; Hudec, M.; & Dittrich, C. (2011). Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncologica, 50(5), 700-710.
66. Mostert, B.; Kraan, J.; Bolt-de Vries, J.; van der Spoel, P.; Sieuwerts, A. M.; Schutte, M.; Timmermans, A. M.; Foekens, R.; Martens, J. W.; Gratama, J. W.; Foekens, J. A.; & Sleijfer, S. (2011). Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Research & Treatment, 127(1), 33-41.
67. Marth, C.; Kisic, J.; Kaern, J.; Tropé, C.; & Fodstad, O. (2002). Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer, 94(3), 707-712.
68. Sieuwerts, A. M.; Kraan, J.; Bolt, J.; van der Spoel, P.; Elstrodt, F.; Schutte, M.; Martens, J. W.; Gratama, J. W.; Sleijfer, S.; & Foekens, J. A. (2009). Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Journal of the National Cancer Instutute, 101(1), 61-66.
69. Aktas, B.; Kasimir-Bauer, S.; Heubner, M.; Kimmig, R.; & Wimberger, P. (2011). Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. International Journal of Gynecological Cancer, 21(5), 822-830.
70. de Albuquerque, A.; Kubisch, I.; Breier, G.; Stamminger, G.; Fersis, N.; Eichler, A.; Kaul, S.; & Stölzel, U. (2012). Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology, 82(1), 3-10.
71. Joosse, S. A.; Hannemann, J.; Spötter, J.; Bauche, A.; Andreas, A.; Müller, V.; & Pantel, K. (2012). Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells. Clinical Cancer Research, 18(4), 993-1003.
72. Effenberger, K. E.; Borgen, E.; Eulenburg, C. Z.; Bartkowiak, K.; Grosser, A.; Synnestvedt, M.; Kaaresen, R.; Brandt, B.; Nesland, J. M.; Pantel, K.; & Naume, B. (2011). Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Research and Treatment, 125(3), 729-738.
73. Christiansen, J. J.; & Rajasekaran, A. K. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research, 66(17), 8319-8326.
74. Raimondi, C.; Gradilone, A.; Naso, G.; Vincenzi, B.; Petracca, A.; Nicolazzo, C.; Palazzo, A.; Saltarelli, R.; Spremberg, F.; Cortesi, E.; & Gazzaniga, P. (2011). Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Research & Treatment, 130(2), 449-455.
75. Gunasinghe, N. P. A. D.; Welss, A.; Thompson, E. W.; & Hugo, H. J. (2012). Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer & Metastasis Reviews. doi: 10.1007/s10555-012-9377-5.
76. Grabinski, N.; Bartkowiak, K.; Grupp, K.; Brandt, B.; Pantel, K.; & Jücker, M. (2011). Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Cellular Signalling, 23(12), 1952-1960.
77. Matrone, M. A.; Whipple, R. A.; Balzer, E. M.; & Martin, S. S. (2010). Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells. Cancer Research, 70(20), 7737-7741.
78. Yokoyama, K.; Kamata, N.; Fujimoto, R.; Tsutsumi, S.; Tomonari, M.; Taki, M.; Hosokawa, H.; & Nagayama, M. (2003). Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. International Journal of Oncology, 22(4), 891-898.
79. Mani, S. A.; Guo, W.; Liao, M. J.; Eaton, E. N.; Ayyanan, A.; Zhou, A. Y.; Brooks, M.; Reinhard, F.; Zhang, C. C.; Shipitsin, M.; Campbell, L. L.; Polyak, K.; Brisken, C.; Yang, J.; & Weinberg, R. A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704-715.
80. May, C. D.; Sphyris, N.; Evans, K. W.; Werden, S. J.; Guo, W.; & Mani, S. A. (2011). Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Research, 13(1), 202.
81. Kong, D.; Banerjee, S.; Ahmad, A.; Li, Y.; Wang, Z.; Sethi, S.; & Sarkar, F. H. (2010). Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. Public Library of Science One, 5(8), e12445.
82. Giannoni, E.; Bianchini, F.; Calorini, L.; & Chiarugi, P. (2011). Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxidants and Redox Signaling, 14(12), 2361-2371.
83. Toh, B.; Wang, X.; Keeble, J.; Sim, W. J.; Khoo, K.; Wong, W. C.; Kato, M.; Prevost-Blondel, A.; Thiery, J. P.; & Abastado, J. P. (2011). Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. Public Library of Science Biology, 9(9), e1001162.
84. Cooke, V. G.; Lebleu, V. S.; Keskin, D.; Khan, Z.; O'Connell, J. T.; Teng, Y.; Duncan, M. B.; Xie, L.; Maeda, G.; Vong, S.; Sugimoto, H.; Rocha, R. M.; Damascena, A.; Brentani, R. R.; & Kalluri, R. (2012). Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by Met signaling pathway. Cancer Cell, 21(1), 66-81.
85. Wells, A.; Yates, C.; & Shepard, C. R. (2008). E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical and Experimental Metastasis, 25(6), 621-628.
86. Chao, Y.; Wu, Q.; Acquafondata, M.; Dhir, R.; & Wells, A. (2011). Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Epub ahead of print: Cancer Microenvironment.
87. Hazan, R. B.; Qiao, R.; Keren, R.; Badano, I.; & Suyama, K. (2004). Cadherin switch in tumor progression. Annals of the New York Academy of Sciences, 1014(1), 155-163.
88. Satelli, A.; & Li, S. (2011). Vimentin in cancer and its potential as a molecular target for cancer therapy. Cellular and Molecular Life Sciences, 68(18), 3033-3046.
89. Bastid, J. (2012). EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Epub ahead of print: Cancer and Metastasis Review.
90. Friedl, P.; & Alexander, S. (2011). Cancer invasion and the microenvironment: plasticity and reciprocity. Cell, 147(5), 992-1009.
91. Nieto, M. A. (2011). The ins and outs of the epithelial to mesenchymal transition in health and disease. Annual Review of Cell and Developmental Biology, 27, 347-376.
92. Alpaugh, M. L.; Tomlinson, J. S.; Kasraeian, S.; & Barsky, S. H. (2002). Cooperative role of E-cadherin and sialyl-Lewis X/A-de ® cient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene, 21(22), 3631-3643.
93. Bonnomet, A.; Syne, L.; Brysse, A.; Feyereisen, E.; Thompson, E. W.; Noël, A.; Foidart, J.-M.; et al. (2011). A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. doi: 10.1038/onc.2011.540.
94. Howard, E. W.; Leung, S. C.; Yuen, H. F.; Chua, C. W.; Lee, D. T.; Chan, K. W.; Wang, X.; & Wong, Y. C. (2008). Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clinical and Experimental Metastasis, 25(5), 497-508.
95. Loric, S.; Paradis, V.; Gala, J. L.; Berteau, P.; Bedossa, P.; Benoit, G.; & Eschwège, P. (2001). Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. European Journal of Cancer, 37(12), 1475-1481.
96. Saad, A. A.; Awed, N. M.; Abd Elkerim, N. N.; El-Shennawy, D.; Alfons, M. A.; Elserafy, M. E.; Darwish, Y. W.; et al. (2010). Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients. Annals of Surgical Oncology, 17(1), 3059-3067.
97. Setoyama, T.; Natsugoe, S.; Okumura, H.; Matsumoto, M.; Uchikado, Y.; & Aikou, T. (2007). Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. British Journal of Surgery, 94(8), 984-991.
98. Armstrong, A. J.; Marengo, M. S.; Oltean, S.; Kemeny, G.; Bitting, R.; Turnbull, J.; Herold, C. I.; et al. (2011). Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Molecular Cancer Research, 9(8), 997-1007.
99. Labelle, M.; Begum, S.; & Hynes, R. O. (2011). Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell, 20(5), 576-590.
100. Padua, D.; Zhang, X. H.; Wang, Q.; Nadal, C.; Gerald, W. L.; Gomis, R. R.; & Massagué, J. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell, 133(1), 66-77.
101. Giampieri, S.; Manning, C.; Hooper, S.; Jones, L.; Hill, C. S.; & Sahai, E. (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biology, 11(11), 1287-1296.
102. Meng, S.; Tripathy, D.; Frenkel, E. P.; Shete, S.; Naftalis, E. Z.; Huth, J. F.; Beitsch, P. D.; Leitch, M.; Hoover, S.; Euhus, D.; Haley, B.; Morrison, L.; Fleming, T. P.; Herlyn, D.; Terstappen, L. W.; Fehm, T.; Tucker, T. F.; Lane, N.; Wang, J.; & Uhr, J. W. (2004). Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research, 10(24), 8152-8162.
103. Yates, C. C.; Shepard, C. R.; Stolz, D. B.; & Wells, A. (2007). Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. British Journal of Cancer, 96(8), 1246-1252.
104. Gherardi, E.; Birchmeier, W.; Birchmeier, C.; & Woude, G. V. (2012). Targeting MET in cancer: rationale and progress. Nature Reviews Cancer, 12, 89-103.
105. Aokage, K.; Ishii, G.; Ohtaki, Y.; Yamaguchi, Y.; Hishida, T.; Yoshida, J.; Nishimura, M.; Nagai, K.; & Ochiai, A. (2011). Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. International Journal of Cancer, 128(7), 1585-1595.
106. Putz, E.; Witter, K.; Offner, S.; Models, W.; Stosiek, P.; Zippelius, A.; Johnson, J.; et al. (1999). Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Research, 59(1), 241-248.
107. Willipinski-Stapelfeldt, B.; Riethdorf, S.; Assmann, V.; Woelfle, U.; Rau, T.; Sauter, G.; Heukeshoven, J.; & Pantel, K. (2005). Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clinical Cancer Research, 11(22), 8006-8014.
108. Bartkowiak, K.; Wieczorek, M.; Buck, F.; Harder, S.; Moldenhauer, J.; Effenberger, K. E.; Pantel, K.; Pater-Katalanic, J.; & Brandt, B. H. (2009). Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/progenitor cell protein profile. Journal of Proteome Research, 9(6), 3158-3168.
109. Dachs, G. U.; & Tozer, G. M. (2000). Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. European Journal of Cancer, 36, 1649-1660.
110. Jiang, J.; Tang, Y. L.; & Liang, X. H. (2011). EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther.; 11(8), 714-723.
111. Kallergi, G.; Markomanolaki, H.; Giannoukaraki, V.; Papadaki, M. A.; Strati, A.; Lianidou, E. S.; Georgoulias, V.; Mavroudis, D.; & Agelaki, S. (2009). Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Research, 11(6), R84.
112. Ameri, K.; Luong, R.; Zhang, H.; Powell, A. A.; Montgomery, K. D.; Espinosa, I.; Bouley, D. M.; Harris, A. L.; & Jeffrey, S. S. (2010). Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. British Journal of Cancer, 102(3), 561-569.
113. Bartkowiak, K.; Riethdorf, S.; & Pantel, K. (2011). The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis. Cancer Microenvironment, 5, 59-72.
114. Valdés, F.; Alvarez, A. M.; Locascio, A.; Vega, S.; Herrera, B.; Fernández, M.; Benito, M.; Nieto, M. A.; & Fabregat, I. (2002). The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Molecular Cancer Research, 1(1), 68-78.
115. Barrallo-Gimeno, A.; & Nieto, M. A. (2005). The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development, 132(14), 3151-3161.
116. Peinado, H.; Olmeda, D.; & Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews Cancer, 7(6), 415-428.
117. Kurrey, N. K.; Jalgaonkar, S. P.; Joglekar, A. V.; Ghanate, A. D.; Chaskar, P. D.; Doiphode, R. Y.; & Bapat, S. A. (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 27(9), 2059-2068.
118. Chen, X.; Lingala, S.; Khoobyari, S.; Nolta, J.; Zern, M. A.; & Wu, J. (2011). Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. Journal of Hepatology, 55(4), 838-845.
119. Theys, J.; Jutten, B.; Habets, R.; Paesmans, K.; Groot, A. J.; Lambin, P.; Wouters, B. G.; Lammering, G.; & Vooijs, M. (2011). E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiotherapy and Oncology, 99(3), 392-397.
120. Bartkowiak, K.; Effenberger, K. E.; Harder, S.; Andreas, A.; Buck, F.; Peter-Katalinic, J.; Pantel, K.; & Brandt, B. H. (2010). Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. Journal of Proteome Research, 9(6), 3158-3168.
121. Prunotto, M.; Compagnone, A.; Bruschi, M.; Candiano, G.; Colombatto, S.; Bandino, A.; Petretto, A.; Moll, S.; Bochaton-Piallat, M. L.; Gabbiani, G.; Dimuccio, V.; Parola, M.; Citti, L.; & Ghiggeri, G. (2010). Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells. Lab Investigation, 90(6), 929-939.
122. Zhong, Q.; Zhou, B.; Ann, D. K.; Minoo, P.; Liu, Y.; Banfalvi, A.; Krishnaveni, M. S.; Dubourd, M.; Demaio, L.; Willis, B. C.; Kim, K. J.; duBois, R. M.; Crandall, E. D.; Beers, M. F.; & Borok, Z. (2011). Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. American Journal of Respiratory Cell and Molecular Biology, 45(3), 498-509.
123. Wouters, B. G.; & Koritzinsky, M. (2008). Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews Cancer, 8, 851-864.
124. Voss, M. J.; Möller, M. F.; Powe, D. G.; Niggemann, B.; Zänker, K. S.; & Entschladen, F. (2011). Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism. BMC Cancer, 11, 158.
125. Fernando, R. I.; Castillo, M. D.; Litzinger, M.; Hamilton, D. H.; & Palena, C. (2011). IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Research, 71(15), 5296-5306.
126. Scheel, C.; Eaton, E. N.; Li, S. H.; Chaffer, C. L.; Reinhardt, F.; Kah, K. J.; Bell, G.; Guo, W.; Rubin, J.; Richardson, A. L.; & Weinberg, R. A. (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 145(6), 926-940.
127. Muraoka, R. S.; Dumont, N.; Ritter, C. A.; Dugger, T. C.; Brantley, D. M.; Chen, J.; Easterly, E.; Roebuck, L. R.; Ryan, S.; Gotwals, P. J.; Koteliansky, V.; & Arteaga, C. L. (2002). Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. Journal of Clinical
128. Aktas, B.; Tewes, M.; Fehm, T.; Hauch, S.; Kimmig, R.; & Kasimir-Bauer, S. (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research, 11(4), R46.
129. Gradilone, A.; Raimondi, C.; Nicolazzo, C.; Petracca, A.; Gandini, O.; Vincenzi, B.; Naso, G.; Aglianò, A. M.; Cortesi, E.; & Gazzaniga, P. (2011). Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. Journal of Cellular and Molecular Medicine, 15(5), 1066-1070.
130. Kallergi, G.; Papadaki, M. A.; Politaki, E.; Mavroudis, D.; Georgoulias, V.; & Agelaki, S. (2011). Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Research, 13(3), R59.
131. Markou, A.; Strati, A.; Malamos, N.; Georgoulias, V.; & Lianidou, E. S. (2011). Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clinical Chemistry, 57(3), 421-430.
132. Mego, M.; Mani, S. A.; Lee, B. N.; Li, C.; Evans, K. W.; Cohen, E. N.; Gao, H.; Jackson, S. A.; Giordano, A.; Hortobagyi, G. N.; Cristofanilli, M.; Lucci, A.; & Reuben, J. M. (2012). Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy. International Journal of Cancer, 130(4), 808-816.
133. Strati, A.; Markou, A.; Parisi, C.; Politaki, E.; Mavroudis, D.; Georgoulias, V.; & Lianidou, E. (2011). Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR. BMC Cancer, 11(1), 422.
134. Kasimir-Bauer, S.; Hoffmann, O.; Wallwiener, D.; Kimmig, R.; & Fehm, T. (2012). Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Research, 14(1), R15.
135. Hofman, V.; Ilie, M. I.; Long, E.; Selva, E.; Bonnetaud, C.; Molina, T.; Vénissac, N.; Mouroux, J.; Vielh, P.; & Hofman, P. (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the Cell Search Assay™ and the isolation by size of epithelial tumor cell method. International Journal of Cancer, 129(7), 1651-1660.
136. Lecharpentier, A.; Vielh, P.; Perez-Moreno, P.; Planchard, D.; Soria, J. C.; & Farace, F. (2011). Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. British Journal of Cancer, 105(9), 1338-1341.
137. Devriese, L. A.; Bosma, A. J.; van de Heuvel, M. M.; Heemsbergen, W.; Voest, E. E.; & Schellens, J. H. (2012). Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer, 75(2), 242-247.
138. Wang, N.; Shi, L.; Li, H.; Hu, Y.; Du, W.; Liu, W.; Zheng, J.; Huang, S.; & Qu, X. (2012). Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation. Tumour Biology, 33, 561-569.
139. Gazzaniga, P.; Gradilone, A.; Petracca, A.; Nicolazzo, C.; Raimondi, C.; Iacovelli, R.; Naso, G.; et al. (2010). Molecular markers in circulating tumour cells from metastatic colorectal cancer patients. Journal of Cellular and Molecular Medicine, 14(8), 2073-2077.
140. Gradilone, A.; Iacovelli, R.; Cortesi, E.; Raimondi, C.; Gianni, W.; Nicolazzo, C.; Petracca, A.; Palazzo, A.; Longo, F.; Frati, L.; & Gazzaniga, P. (2011). Circulating tumor cells and suspicious objects evaluated through Cell Search® in metastatic renal cell carcinoma. Anticancer Research, 31(12), 4219-4221.
141. Mor-Vaknin, N.; Punturieri, A.; Sitwala, K.; & Markovitz, D. M. (2003). Vimentin is secreted by activated macrophages. Nature Cell Biology, 5(1), 59-63.
142. Ishii, G.; Ito, T.-K.; Aoyagi, K.; Fujimoto, H.; Chiba, H.; Hasebe, T.; Fujii, S.; et al. (2007). Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients. Stem Cells, 25(6), 1469-1477.
143. Bucala, R.; Spiegel, L. A.; Chesney, J.; Hogan, M.; & Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine, 1(1), 71-81.
144. Barth, P. J.; & Westhoff, C. C. (2007). CD34+ fibrocytes: morphology, histogenesis and function. Current Stem Cell Research and Therapy, 2(3), 221-227.
145. Kitamura, N.; Nishinarita, S.; Takizawa, T.; Tomita, Y.; & Horie, T. (2000). Cultured human monocytes secrete fibronectin in response to activation by proinflammatory cytokines. Clinical and Experimental Immunology, 120(1), 66-70.
146. Campbell, I.; Qiu, W.; & Haviv, I. (2011). Genetic changes in tumour microenvironments. Journal of Pathology, 223(4), 450-458.